A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
Genentech, Inc.
M.D. Anderson Cancer Center
LG Chem
Exelixis
Genentech, Inc.
Bayer
Exelixis
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Fundacion Oncosur
Pieris Pharmaceuticals, Inc.
Centre Georges Francois Leclerc
Icahn School of Medicine at Mount Sinai
Fate Therapeutics
Hoffmann-La Roche
Corvus Pharmaceuticals, Inc.
Hoffmann-La Roche
Celldex Therapeutics